A study in August's issue of the Clinical Gastroenterology & Hepatology reports racial and ethnic disparities in colonoscopic examination of individuals with a family history of colorectal cancer.
Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis, reports this month's issue of Gastroenterology.
Published ahead of print, a study in the Alimentary Pharmacology & Therapeutics reviews the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers.
A study in this month's Clinical Gastroenterology & Hepatology identifies gender differences in fecal immunochemical test performance for early detection of colorectal neoplasia.
August's publication of Gastroenterology evaluates trends in adenoma detection rates during the first 10 years of the German screening colonoscopy program.
The most recent issue of the Inflammatory Bowel Diseases examines the chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis.
The latest issue of Inflammatory Bowel Diseases examines volatile organic compounds in exhaled air as a novel marker for disease activity in Crohn's disease.
Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis, reports the latest issue of Gastroenterology.
August's issue of the Inflammatory Bowel Diseases compares the effectiveness of nutritional and biological therapy in North American children with active Crohn's disease.
A study in the most recent issue of the Diseases of the Colon & Rectum compares pursestring closure with conventional primary closure following stoma reversal to reduce surgical site infection rate.
A study in the latest issue of Gut developed a genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration.
A study published ahead of print the Alimentary Pharmacology & Therapeutics reports an increased risk of hepatocellular carcinoma in chronic HCV patients with new onset diabetes.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .